<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> in obstetrics represents a striking model of maternofetal pathology related to systemic and intraplacental <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Two pro-coagulant antibodies are now well known: <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and anticardiolipin antibody </plain></SENT>
<SENT sid="2" pm="."><plain>Therapy is preventive and efficient </plain></SENT>
<SENT sid="3" pm="."><plain>It is based on a cautious choice from three drugs: aspirin, <z:chebi fb="5" ids="28304">heparin</z:chebi>, and <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> </plain></SENT>
</text></document>